I am an expert in managing patients with multiple myeloma, amyloidosis and other plasma cell disorders. I have conducted National Institutes of Health (NIH)-supported lab research but now focus my efforts on clinical research in 1) treating multiple myeloma in patients who are at high risk for toxicity due to advanced age or other medical problems, 2) developing novel drugs for treating all patients with multiple myeloma and 3) optimizing management for amyloidosis. I am a member of international working groups that formulate guidelines for treating these disorders, and I have won multiple awards for teaching and research accomplishments.
Partial Data by Infogroup (c) 2024. All rights reserved.